Moody Aldrich Partners’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-26,692
| Closed | -$1.9M | – | 134 |
|
|
2019
Q2 | $1.9M | Buy |
26,692
+1,054
| +4% | +$75.1K | 0.49% | 77 |
|
|
2019
Q1 | $2.01M | Sell |
25,638
-11,946
| -32% | -$937K | 0.56% | 69 |
|
|
2018
Q4 | $3.18M | Buy |
37,584
+4,128
| +12% | +$349K | 1.04% | 42 |
|
|
2018
Q3 | $5.73M | Sell |
33,456
-8,914
| -21% | -$1.53M | 1.65% | 15 |
|
|
2018
Q2 | $5.48M | Buy |
+42,370
| New | +$5.48M | 1.95% | 10 |
|